bio personality
Aditya Narayan elected as chairman of Sanofi India
Sanofi India has announced the election of Mr Aditya Narayan as the Chairman of the Board of Directors . Mr Narayan has rich experience in industry for over 40 years . He served ICI Limited , now Akzo Nobel India Limited , for about 30 years across diverse functions and businesses . He was its Managing Director during 1996-2003 and then its non-executive Chairman over 2003 - 2010 . Over 2005-2009 , he was the President and CEO of BHP Billiton India . He has also served on a number of other Boards . Presently , he is an Independent Director of Hindustan Unilever Limited , Linde India Limited and , Chambal Fertilizers and Chemicals Limited .
“ Sanofi welcomes Mr Narayan , with his commendable track record as a corporate leader , to guide it through the emerging complexities in the Indian pharmaceutical environment ,” said Dr Shailesh Ayyangar , Managing Director – Sanofi India Limited .
Commenting on his new role as Chairman of Sanofi India Limited , Mr Aditya Narayan , mentioned , “ Sanofi has a superb track record of building strong pharmaceutical brands , several of which are now household names . Its world class manufacturing facilities and ethical marketing practices enjoy a reputation for excellence in serving its growing customers in India and overseas . It is a privilege for me to have been entrusted with the role of the Chairman of the Board of Directors and I look forward to the support of all its stakeholders in discharging my responsibilities .”
Dr Rakesh Mishra appointed as the new Director of CCMB , Hyderabad
The well known bio-scientist , Dr Rakesh Kumar Mishra , has taken over as the new Director of Hyderabad based Centre for Cellular and Molecular Biology ( CCMB ), a premier research organization in frontier areas of modern biology . The institute is affiliated to the Council for Scientific and Industrial Research ( CSIR ) under the Ministry of Science and Technology , Government of India .
Dr Mishra was previously working as the Senior Principal Scientist and Group Leader at the the Genome Organisation and Nuclear Architecture laboratory based at the CCMB itself . Well recognized for his research achievements , Dr Mishra is an elected fellow of many reputed bodies such as the Indian Academy of Sciences , National Academy of Sciences , Indian National Academy of Sciences and Andhra Pradesh Academy of Sciences . He has more than 95 articles to his credit in the national and international journals .
Dr Rakesh K Mishra obtained his Masters degree in Chemistry in 1981 and doctorate in Organic Chemistry in 1986 from the University of Allahabad . His research then was into non-B DNA conformations and DNA topolgy at Molecular Biophysics Unit , Indian Institute of Science , Bangalore . During 1988-1992 , he worked at CCMB as scientist and then at Saint Louis University School of Medicine , USA . From the 1996 to 2001 , Dr Mishra worked on the chromatin organization and regulation of homeotic gene complex of Drosophila melanogaster at the University of Geneva , Switzerland . During 2001 , he came back to India and joined CCMB again .
Narayanan Suresh is the new COO of ABLE
After a 30-year stint as a professional editor and journalist that ended on April 30 , 2016 , Mr Narayanan Suresh has formally joined the Association of Biotechnology Led Enterprises ( ABLE ) on May 2 , 2016 as its Chief Operating Officer ( COO ). He will be based out of the ABLE secretariat in Bangalore . The association was founded in 2003 to represent the interests of the fast-growing biotechnology industry .
For more than 13 years as the Editor of BioSpectrum , Mr N Suresh has worked closely with the biotech sector . Therefore , his rich experience and knowledge are expected to benefit the industry in due course of time . From being a neutral observer to the biotech industry insider , his second innings now allows him to continue the association with sector .
The meeting of ABLE ’ s Executive Council on Monday , 9th May specifically gave him the challenging task of ensuring an orderly growth of the industry , increase the engagement levels within and outside the industry , set up a robust information sharing network , interface with policy makers , regulators and the wide range of stakeholders and make the organization the hub of activities for the hundreds of startups in the biotech sector .
Raj Ketkar named CEO of Arcadia Biosciences
Raj Ketkar has joined the Arcadia Biosciences as president and chief executive officer later this month . Mr Ketkar will replace Mr Roger Salameh , who has served as interim president and CEO since February . Mr Salameh will take on a new role as chief operating officer for the company , reporting to the CEO .
Mr Ketkar brings nearly 35 years of agriculture and agricultural biotechnology business experience in the US and internationally . He spent more than 30 years in a variety of business , operations , and strategy roles for Monsanto Company , during which time he demonstrated successes in agricultural trait commercialization and growth around the globe .
As managing director of the Mahyco-Monsanto joint venture in India , Mr Ketkar led the launch of Bt cotton , the country ' s first agricultural biotechnology product . In addition to his operations and trait commercialization experience , Mr Ketkar was also director of biotechnology strategy for Monsanto , where he led the development of the company ' s trait stacking technology .
" With a number of breakthrough yield and stress traits in the late stages of development , Arcadia is at an exciting stage as a company ," said Mr Ketkar . " I look forward to build upon the company ' s achievements and improve the productivity and environmental sustainability of agriculture ," he said .
BIOVOICENEWS . COM 13